Not finding it? Sign in to also search OpenAlex live.
-
Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data2023 European Journal Of Haematology article Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Koo Wilson, Jesse Fishman, Piotr Wojciechowski, Marlena Wdowiak, Regina Horneff, +3 more
6citations -
RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA2020 Hematology Transfusion and Cell Therapy article Immunology and Microbiology Complement system in diseases Open access
Peter Hillmen, Jeff Szer, Britta Höchsmann, Jens Panse, Jean‐Jacques Kiladjian, Carlos M. DeCastro, +7 more
3citations -
POSTER: MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia2023 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Eros Di Bona, Morag Griffin, +27 more
0citations -
POSTER: MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin GKulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations -
Poster: MDS-112 Normalization of Hematologic and Health-Related Quality of Life Markers in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Pegcetacoplan and Baseline Hemoglobin at or Above 10 g/dL2022 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Dharmik Desai, Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, +5 more
0citations -
POSTER: MDS-1167: Long-Term Hematologic Control and Safety in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Iptacopan: Six-Year Follow-Up From Phase 2 Studies and Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations -
WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS2026 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
Andrew S. Bomback, Carla Nester, Richard J.H. Smith, Liz Lightstone, Marina Vivarelli, Sophie Chauvet, +7 more
0citations -
Poster: MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment2021 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Ilene Ceil Weitz, Régis Peffault de Latour, Jeff Szer, Alexander Röth, Britta Höchsmann, Jens Panse, +12 more
0citations -
Essai de phase III randomisé, multicentrique et en ouvert COMMODORE 1 : comparaison du crovalimab et de l’éculizumab chez des patients atteints d’hémoglobinurie paroxystique nocturne (HPN) déjà traités par un inhibiteur du complément
C. Tessier, Louis Terriou, Phillip Scheinberg, Diego V. Clé, Valentina Giai, M. Hus, +10 more
0citations -
Antifouling Surface‐Attached Hydrogel Nanocoatings Redefined: Green Solvent‐Based, Degradable, and High‐Performance Protection Against Foulants2025 Advanced Materials Interfaces article Materials Science Polymer Surface Interaction Studies Open access
Jenny Englert, Marc Palà, Jonas Quandt, Hannah Sieben, Oliver Grottke, Gerard Lligadas, +1 more
1citations -
POS0253 DIFFERENCES IN THE EFFECT OF C4A and C4B COPY NUMBERS ON SSc SEROLOGICAL AND CLINICAL SUBTYPES2025 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access
Joaquín Martínez‐López, Carlos Rangel‐Peláez, Inmaculada Rodriguez‐Martin, Alfredo Guillén del Castillo, Carmen Pilar Simeón‐Aznar, José Luís Callejas-Rubio, +14 more
0citations -
The future role of thermal energy storage in 100% renewable electricity systems2023 Renewable and Sustainable Energy Transition article Engineering Integrated Energy Systems Optimization Open access
Rhys Jacob, Maximilian Hoffmann, Jann Michael Weinand, Jochen Linßen, Detlef Stolten, Michael Rolf Müller
24citations -
Toward an Operational Anthropogenic CO2 Emissions Monitoring and Verification Support Capacity2020 Bulletin of the American Meteorological Society article Environmental Science Atmospheric and Environmental Gas Dynamics Open access
Greet Janssens‐Maenhout, B. Pinty, Mark D. Dowell, H. Zunker, Erik Andersson, Gianpaolo Balsamo, +34 more
205citations -
Profiling of intact blood proteins by matrix‐assisted laser desorption/ionization mass spectrometry without the need for freezing – Dried serum spots as future clinical tools for patient screening2021 Rapid Communications in Mass Spectrometry article Chemistry Mass Spectrometry Techniques and Applications
Charles A. Okai, Manja Wölter, Manuela Ruß, Cornelia Koy, Brîndușa Alina Petre, Werner H. Rath, +2 more
5citations -
Clinical stance on response initiation in autistic adults: co-creating an integrative approach based on theory and lived experiences to act from language, via motor movement to wellbeing
Kirstin Greaves‐Lord, Manna Alma, Benjamin de Graaff, Johanna Landsman-Dijkstra, Klaske van der Weide, Gabrine Jagersma, +10 more
3citations